EUVIMEDEUVIMED entdecken
Crossref

Silencing Interleukin-6 and Glycoprotein 130 Suppresses Growth and Induces Apoptosis in Cancer Cells

Parastoo Khodayari, Atefeh Khodakarami, Hadi Hassannia, Ghasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Vida Hashemi, Farhad Jadidi-Niaragh

International Journal of Drug Research in Clinics · 2023

DOI: 10.34172/ijdrc.2023.e8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Research in Clinics, 2023. Verfasst von Parastoo Khodayari und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Various signaling pathways promote cancer growth and inhibit apoptosis in cancerous cells. The increased levels of interleukin (IL)-6 cytokine and its signaling by IL-6 receptors have been reported in various cancers, which were associated with poor prognosis. On the other hand, targeting IL-6 and IL-6 receptors was associated with ameliorating effects in cancers. Therefore, this study sought to inhibit both IL-6 and its receptor (glycoprotein 130, [gp130]) and to synergistically reduce cancer progression in vitro.

Methods

Accordingly, 4T1 and CT26 cancer cell lines were used to analyze the efficacy of the simultaneous blockade of IL-6 and gp130. In addition, small interfering ribonucleic acid (siRNA) molecules were employed to suppress the expression of these factors. The expression of target genes was investigated using the quantitative real-time polymerase chain reaction assay. Further, an MTT assay was applied to study cell survival. Finally, cytokine was measured by enzyme-linked immunosorbent assay.

Results

The transfection of cancer cells by lipofectamine led to significant downregulation of these factors in both cell lines. Moreover, the downregulation of IL-6 and gp130 caused significant cell death induction, which was associated with the reduced proliferative potential of both cells. Eventually, IL-6 silencing markedly suppressed the secretion of IL-6 in both cells.

Conclusion

These findings imply that the simultaneous silencing of IL-6 and gp130 can be considered a potential anticancer therapeutic approach that should be further considered in future studies.

Zitieren

APA

Khodayari, P., Khodakarami, A., Hassannia, H., Ghalamfarsa, G., Hojjat-Farsangi, M., Hashemi, V., & Jadidi-Niaragh, F. (2023). Silencing Interleukin-6 and Glycoprotein 130 Suppresses Growth and Induces Apoptosis in Cancer Cells. International Journal of Drug Research in Clinics. https://doi.org/10.34172/ijdrc.2023.e8

Vancouver

Khodayari P, Khodakarami A, Hassannia H, Ghalamfarsa G, Hojjat-Farsangi M, Hashemi V, et al. Silencing Interleukin-6 and Glycoprotein 130 Suppresses Growth and Induces Apoptosis in Cancer Cells. International Journal of Drug Research in Clinics. 2023. doi:10.34172/ijdrc.2023.e8

BibTeX
@article{Khodayari2023,
  author = {Khodayari, Parastoo and Khodakarami, Atefeh and Hassannia, Hadi and Ghalamfarsa, Ghasem and Hojjat-Farsangi, Mohammad and Hashemi, Vida and Jadidi-Niaragh, Farhad},
  title = {Silencing Interleukin-6 and Glycoprotein 130 Suppresses Growth and Induces Apoptosis in Cancer Cells},
  journal = {International Journal of Drug Research in Clinics},
  year = {2023},
  doi = {10.34172/ijdrc.2023.e8}
}
Kostenlos starten →